Prospective Non-interventional Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment (CABOCARE) First published 11/01/2024 Last updated 05/01/2026 EU PAS number:EUPAS108004 Study Ongoing